rs878854714

Variant names:

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_004612.4(TGFBR1):c.49C>T(p.Leu17Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000167 in 1,054,174 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. L17L) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00019 ( 0 hom., cov: 32)

Exomes 𝑓: 0.00016 ( 0 hom. )

Consequence

TGFBR1
NM_004612.4 synonymous

Scores

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:6

Conservation

PhyloP100: -0.109

Publications

0 publications found

Variant links:

Genes affected

TGFBR1 (HGNC:11772): (transforming growth factor beta receptor 1) The protein encoded by this gene forms a heteromeric complex with type II TGF-beta receptors when bound to TGF-beta, transducing the TGF-beta signal from the cell surface to the cytoplasm. The encoded protein is a serine/threonine protein kinase. Mutations in this gene have been associated with Loeys-Dietz aortic aneurysm syndrome (LDAS). Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]

TGFBR1 Gene-Disease associations (from GenCC):

familial thoracic aortic aneurysm and aortic dissection
Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
Loeys-Dietz syndrome
Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
Loeys-Dietz syndrome 1
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P
multiple self-healing squamous epithelioma
Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics, ClinGen

TGFBR1 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.77).

BP6

Variant 9-99105254-C-T is Benign according to our data. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962. Variant chr9-99105254-C-T is described in CliVar as Conflicting_classifications_of_pathogenicity. Clinvar id is 239962.

BP7

Synonymous conserved (PhyloP=-0.109 with no splicing effect.

BS1

Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.000195 (28/143628) while in subpopulation AMR AF = 0.00123 (18/14592). AF 95% confidence interval is 0.000796. There are 0 homozygotes in GnomAd4. There are 14 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.

BS2

High AC in GnomAd4 at 28 AD gene.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
TGFBR1	NM_004612.4 link	c.49C>T	p.Leu17Leu	synonymous_variant	Exon 1 of 9	ENST00000374994.9	NP_004603.1	P36897-1Q5T7S2B4DXN7

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
TGFBR1	ENST00000374994.9 link	c.49C>T	p.Leu17Leu	synonymous_variant	Exon 1 of 9	1	NM_004612.4	ENSP00000364133.4		P36897-1

Frequencies

GnomAD3 genomes

AF:

0.000195

AC:

AN:

143628

Hom.:

Cov.:

show subpopulations

Gnomad AFR

AF:

0.0000753

Gnomad AMI

AF:

0.00

Gnomad AMR

AF:

0.00123

Gnomad ASJ

AF:

0.00

Gnomad EAS

AF:

0.00

Gnomad SAS

AF:

0.00

Gnomad FIN

AF:

0.00

Gnomad MID

AF:

0.00

Gnomad NFE

AF:

0.000108

Gnomad OTH

AF:

0.00

GnomAD2 exomes

AF:

0.00

AC:

AN:

654

AF XY:

0.00

Gnomad AFR exome

AF:

0.00

Gnomad AMR exome

AF:

0.00

Gnomad ASJ exome

AF:

0.00

Gnomad FIN exome

AF:

0.00

Gnomad NFE exome

AF:

0.00

Gnomad OTH exome

AF:

0.00

GnomAD4 exome

AF:

0.000163

AC:

148

AN:

910546

Hom.:

Cov.:

AF XY:

0.000166

AC XY:

AN XY:

427830

show subpopulations

African (AFR)

AF:

0.00

AC:

AN:

17632

American (AMR)

AF:

0.000668

AC:

AN:

2992

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

7598

East Asian (EAS)

AF:

0.00

AC:

AN:

9610

South Asian (SAS)

AF:

0.00

AC:

AN:

18124

European-Finnish (FIN)

AF:

0.00

AC:

AN:

6170

Middle Eastern (MID)

AF:

0.00

AC:

AN:

2014

European-Non Finnish (NFE)

AF:

0.000176

AC:

143

AN:

814462

Other (OTH)

AF:

0.0000939

AC:

AN:

31944

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.496

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.000195

AC:

AN:

143628

Hom.:

Cov.:

AF XY:

0.000201

AC XY:

AN XY:

69788

show subpopulations

African (AFR)

AF:

0.0000753

AC:

AN:

39844

American (AMR)

AF:

0.00123

AC:

AN:

14592

Ashkenazi Jewish (ASJ)

AF:

0.00

AC:

AN:

3372

East Asian (EAS)

AF:

0.00

AC:

AN:

5038

South Asian (SAS)

AF:

0.00

AC:

AN:

4714

European-Finnish (FIN)

AF:

0.00

AC:

AN:

8148

Middle Eastern (MID)

AF:

0.00

AC:

AN:

302

European-Non Finnish (NFE)

AF:

0.000108

AC:

AN:

64780

Other (OTH)

AF:

0.00

AC:

AN:

1966

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.489

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.000142

Hom.:

Bravo

AF:

0.000268

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Uncertain:2Benign:6

Revision: criteria provided, conflicting classifications

LINK: link

Submissions by phenotype

Familial thoracic aortic aneurysm and aortic dissection

Benign:3

Jun 28, 2021

Ambry Genetics

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Jan 29, 2025

Labcorp Genetics (formerly Invitae), Labcorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Feb 14, 2018

CHEO Genetics Diagnostic Laboratory, Children's Hospital of Eastern Ontario

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

not provided

Uncertain:1Benign:1

Oct 01, 2016

CeGaT Center for Human Genetics Tuebingen

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Nov 27, 2020

GeneDx

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

Loeys-Dietz syndrome 1

Uncertain:1

Apr 28, 2017

Illumina Laboratory Services, Illumina

Significance:Uncertain significance

Review Status:criteria provided, single submitter

Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. -

not specified

Benign:1

Mar 06, 2023

Women's Health and Genetics/Laboratory Corporation of America, LabCorp

Significance:Likely benign

Review Status:criteria provided, single submitter

Collection Method:clinical testing

- -

TGFBR1-related disorder

Benign:1

Dec 10, 2022

PreventionGenetics, part of Exact Sciences

Significance:Likely benign

Review Status:no assertion criteria provided

Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.77

CADD

Benign

(source)

DANN

Benign

0.97

PhyloP100

-0.11

PromoterAI

0.038

Neutral

(source)

Mutation Taster

=100/0

polymorphism

(source)

Splicing

Name

Calibrated prediction

Score

Prediction

SpliceAI score (max)

0.0

Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Submissions by phenotype

Computational scores

Splicing

Publications

Other links and lift over